1. Home
  2. MTEX vs VVOS Comparison

MTEX vs VVOS Comparison

Compare MTEX & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEX
  • VVOS
  • Stock Information
  • Founded
  • MTEX 1993
  • VVOS 2016
  • Country
  • MTEX United States
  • VVOS United States
  • Employees
  • MTEX N/A
  • VVOS N/A
  • Industry
  • MTEX Medicinal Chemicals and Botanical Products
  • VVOS Medical Specialities
  • Sector
  • MTEX Health Care
  • VVOS Health Care
  • Exchange
  • MTEX Nasdaq
  • VVOS Nasdaq
  • Market Cap
  • MTEX 23.0M
  • VVOS 19.4M
  • IPO Year
  • MTEX 1999
  • VVOS 2020
  • Fundamental
  • Price
  • MTEX $12.07
  • VVOS $4.54
  • Analyst Decision
  • MTEX
  • VVOS Strong Buy
  • Analyst Count
  • MTEX 0
  • VVOS 2
  • Target Price
  • MTEX N/A
  • VVOS $6.30
  • AVG Volume (30 Days)
  • MTEX 6.9K
  • VVOS 220.2K
  • Earning Date
  • MTEX 11-12-2024
  • VVOS 11-14-2024
  • Dividend Yield
  • MTEX N/A
  • VVOS N/A
  • EPS Growth
  • MTEX N/A
  • VVOS N/A
  • EPS
  • MTEX N/A
  • VVOS N/A
  • Revenue
  • MTEX $121,552,000.00
  • VVOS $14,581,000.00
  • Revenue This Year
  • MTEX N/A
  • VVOS $12.35
  • Revenue Next Year
  • MTEX N/A
  • VVOS $26.02
  • P/E Ratio
  • MTEX N/A
  • VVOS N/A
  • Revenue Growth
  • MTEX N/A
  • VVOS 0.54
  • 52 Week Low
  • MTEX $6.75
  • VVOS $1.91
  • 52 Week High
  • MTEX $13.00
  • VVOS $14.20
  • Technical
  • Relative Strength Index (RSI)
  • MTEX 66.59
  • VVOS 65.32
  • Support Level
  • MTEX $10.08
  • VVOS $4.14
  • Resistance Level
  • MTEX $12.40
  • VVOS $5.43
  • Average True Range (ATR)
  • MTEX 0.84
  • VVOS 0.46
  • MACD
  • MTEX 0.18
  • VVOS 0.05
  • Stochastic Oscillator
  • MTEX 85.71
  • VVOS 58.02

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: